RxDoctor Payments Data

Stacey Engel, NP

Primary Care · Greenwood, INNPI 1871900498

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 81 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 16 manufacturers, the largest accounting for just 19.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $866 and has fallen 78.6% since, to $185 in 2023.

$1,503in general payments, 2019–2025

Across 81 payments — averaging $18.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$288
  • GRT US Holding, Inc.$257
  • Redhill Biopharma Inc.$128
  • AstraZeneca$127
  • Gilead$106
  • AbbVie$104
  • plus $492 from 10 others

What the payments were for

  • Food & beverage$1,503100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,503 in reported general payments places this provider in the 80th percentile of 113 primary care providers in Indiana.

See all primary care providers in Indiana

Medicare billing

Part B allowed, 2024
$47,897
Medicare patients
108
Services billed
609

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Buprenorphine22$4,728
ShingrixVaricella-Zoster Ge/As01b/Pf20$4,200
Pantoprazole Sodium14$2,920
Dronabinol19$2,658
Fentanyl17$2,438
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen82$1,905
Oxycodone Hcl75$1,247
Pregabalin23$888
Lidocaine11$784
Tramadol Hcl19$639
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen17$625
Tizanidine Hcl12$478
Clonazepam19$464
Buspirone Hcl34$420
Mirtazapine12$396

Paid to pharmacies, not to this prescriber.

Other primary care in Greenwood

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →